Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $7.58 -0.05 (-0.59%) As of 09/10/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance The Aerovate Therapeutics (AVTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.49%, with a year-to-date return of -91.83%. In the past month, the stock has increased 2.36%, reflecting recent market activity. As of the latest close, Aerovate Therapeutics traded at $7.58 with a market cap of $219.56 million and volume of 35,897 shares. Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.63%1 Month Performance+2.36%3 Month Performance+7.75%Year-To-Date Performance-91.83%1 Year Performance-88.49% AVTE Stock Chart for Friday, September, 12, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/11/2025$7.62$7.58-0.59%$7.75$7.5035,897 shs$219.56 million09/10/2025$7.48$7.62+1.87%$7.67$7.1830,588 shs$220.87 million09/09/2025$7.77$7.48-3.73%$7.94$7.3353,005 shs$216.81 million09/08/2025$7.77$7.77$8.08$7.6157,825 shs$225.21 million09/05/2025$7.50$7.78+3.80%$7.87$7.3246,506 shs$225.50 million09/04/2025$7.62$7.50-1.64%$7.98$7.4350,121 shs$217.24 million09/03/2025$7.90$7.62-3.54%$8.11$7.5778,629 shs$220.87 million09/02/2025$7.90$7.90$8.12$7.7947,960 shs$228.98 million09/01/2025$7.90$7.90$8.12$7.7947,960 shs$228.98 million08/29/2025$7.95$7.95$8.38$7.8368,897 shs$230.43 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$8.03$7.95-1.00%$8.38$7.8368,897 shs$230.43 million08/27/2025$7.90$8.03+1.65%$8.12$7.6973,960 shs$232.75 million08/26/2025$8.23$7.90-4.01%$8.21$7.65111,930 shs$228.98 million08/25/2025$8.23$8.23$8.30$7.18124,811 shs$238.55 million08/22/2025$7.36$7.38+0.27%$7.45$6.71100,416 shs$213.91 million08/21/2025$7.36$7.36$7.64$7.2884,262 shs$213.33 million08/20/2025$7.50$7.36-1.87%$7.64$7.2884,262 shs$213.33 million08/19/2025$7.36$7.50+1.90%$7.62$7.25106,061 shs$217.39 million08/18/2025$7.36$7.36$7.39$6.67186,080 shs$213.33 million08/15/2025$7.33$6.77-7.64%$7.76$6.7179,151 shs$196.23 million08/14/2025$7.39$7.33-0.81%$7.40$7.0970,945 shs$212.46 million08/13/2025$7.40$7.39-0.14%$8.00$7.2979,258 shs$214.20 million08/12/2025$7.49$7.40-1.20%$7.72$7.2169,957 shs$214.49 million08/11/2025$7.49$7.49$7.58$7.1277,779 shs$217.10 million Related Companies Urogen Pharma Stock Chart Trevi Therapeutics Stock Chart Amylyx Pharmaceuticals Stock Chart Phathom Pharmaceuticals Stock Chart Akebia Therapeutics Stock Chart Anavex Life Sciences Stock Chart Immunome Stock Chart Iovance Biotherapeutics Stock Chart ArriVent BioPharma Stock Chart Niagen Bioscience Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTE Stock Alerts